NORDIC PHARMACEUTICALS ApS: Financial statements 2022
CVR: 27430015
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
NORDIC PHARMACEUTICALS ApS (CVR 27430015) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 779,208 and a net result of DKK 83,804 compared with DKK 71,351 the year before. That is an increase of 19.3% compared with the year before. Equity in the 2022 report amounted to DKK 1,502,524. The solvency ratio was 52%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 779,208
- Profit/Loss
- DKK 83,804
- Equity
- DKK 1,502,524
- Total Assets
- DKK 2,890,915
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 779K | 84K | 1.5M | 2 |
| 2021 | - | 653K | 71K | 1.4M | 2 |
| 2020 | - | 602K | 58K | 1.3M | 3 |
| 2019 | - | 1.3M | 26K | 1.3M | 3 |
| 2018 | - | 1.1M | 34K | 1.3M | 3 |
Official annual report
Keep an eye on NORDIC PHARMACEUTICALS ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
NORDIC PHARMACEUTICALS ApS has published its annual report for 2021. Gross profit came to DKK 652,991, and the net result was DKK 71,351.
About NORDIC PHARMACEUTICALS ApS
NORDIC PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 2003. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Lars Bo Holløse Nielsen. The board consists of Knud Benny Junge (chair). The company is owned by Lars Bo Holløse Nielsen and Kea Ok Junge. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -165,886 and a net result of DKK -573,072 compared with DKK -2,664,416 the year before. Equity in the 2025 report amounted to DKK -1,725,613.